DIN 02568926 — EXDENSUR 100 MG
EXDENSUR is a solution of Depemokimab marketed by GLAXOSMITHKLINE INC. The full Depemokimab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02568926
- Brand name
- EXDENSUR
- Active ingredient
- Depemokimab
- Strength
- 100 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- Interleukin-5 (IL-5) inhibitor (monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Depemokimab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02568934 | EXDENSUR | 100 MG | SOLUTION | GLAXOSMITHKLINE INC | MARKETED |